Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study

L Fabritz, C Al-Taie, K Borof, G Breithardt… - European Heart …, 2024 - academic.oup.com
Abstract Background and Aims In patients with atrial fibrillation (AF), recurrent AF and sinus
rhythm during follow-up are determined by interactions between cardiovascular disease …

[HTML][HTML] Injection of ROS-Responsive Hydrogel Loaded with IL-1β-targeted nanobody for ameliorating myocardial infarction

L Wang, C Yu, T You, X Zhang, H Su, B Cao… - Bioactive Materials, 2025 - Elsevier
The cardiac microenvironment profoundly restricts the efficacy of myocardial regeneration
tactics for the treatment of myocardial infarction (MI). A prospective approach for MI …

Does atrial fibrillation ablation prevent cardiovascular death, stroke, and heart failure events?

P Kirchhof, AS Parwani, N Schenker - Heart Rhythm, 2024 - heartrhythmjournal.com
Schematic representation of the 2-dimensional space created by comorbidity burden
(quantified using the CHA2DS2VASc score, y-axis) and heart failure (no heart failure or …